Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Hydroxyurea for Sickle Cell Anemia
Recruiting2 awardsPhase 3
Cleveland, Ohio
This trial will compare a new, individualized dosing strategy of hydroxyurea to standard weight-based dosing for children with SCA, in order to see if the former leads to a better response in terms of fetal hemoglobin levels.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service